• CFDA SE Cell Tracer Kit: Technical Guidance for Stable Cell

  2026-05-21

  The CFDA SE (carboxyfluorescein diacetate succinimidyl ester) Cell Tracer Kit enables robust, long-term fluorescent labeling for tracking cell proliferation and lineage in both in vitro and in vivo assays. This kit is most appropriate for applications that require stable, covalent cell tagging, and is unsuitable for workflows needing reversible or fleeting cell labeling.

• Comparative In Vitro Efficacy of Sisomicin and Tobramycin Ag

  2026-05-21

  This article reviews a landmark study investigating the in vitro activity of sisomicin, a novel aminoglycoside antibiotic, compared to established agents such as gentamicin and tobramycin. The paper's findings clarify the nuanced activity profiles of these antibiotics against a range of Gram-negative and Gram-positive clinical isolates, informing both resistance surveillance and experimental design in microbiology research.

• Nystatin (Fungicidin): Protocols, Applications, and Optimiza

  2026-05-20

  Nystatin (Fungicidin) stands out as a precision antifungal tool for targeted research on Candida and Aspergillus, with clear advantages in membrane disruption and resistance profiling. This article delivers actionable guidance on experimental workflows, troubleshooting, and protocol optimization, grounded in the latest research and product intelligence.

• SN-38 and Camptothecin Disrupt FUBP1–FUSE Binding in Cancer

  2026-05-20

  The referenced study identifies a novel mechanism by which camptothecin and its active analog SN-38 inhibit the DNA-binding activity of the oncogenic regulator FUBP1, in addition to their established topoisomerase I inhibition. These findings suggest dual-pathway interference that may enhance the therapeutic potential of SN-38 in advanced cancer research.

• Syringin Targets EGFR/PI3K/Akt to Enhance Sunitinib in RCC M

  2026-05-19

  The reference study demonstrates that Syringin, a natural product, inhibits renal cell carcinoma (RCC) progression by modulating the EGFR/PI3K/Akt pathway and enhances the efficacy of sunitinib. These findings support Syringin's potential role in overcoming drug resistance in RCC and inform future research on bioactive compounds in targeted cancer therapy.

• ddhCTP and Viperin: Mechanistic Insights for Antiviral Innov

  2026-05-19

  Explore the unique mechanism of ddhCTP (3ʹ-deoxy-3′,4ʹ-didehydro-CTP) in interrupting viral RNA synthesis. This article offers deep scientific insight into how ddhCTP advances antiviral research and assay design, providing a perspective not found in standard workflow guides.

• Ranolazine: Anti-Ischemic Agent for Cardiac and Metabolic Re

  2026-05-18

  Ranolazine is a uniquely dual-acting anti-ischemic agent, inhibiting late sodium currents and optimizing metabolic substrate use in cardiac and liver systems. This article delivers advanced experimental workflows, troubleshooting strategies, and integrative applications for researchers seeking to dissect myocardial relaxation, metabolic modulation, and their interplay with autophagy.

• EGTA Applications: Modulating Calcium Signaling in Cell Mode

  2026-05-18

  EGTA (egtaizic acid) stands out as a selective calcium chelator, enabling precise control over calcium-dependent processes in neuroprotection and endothelial inflammation models. This article translates leading-edge research into actionable protocols, troubleshooting guidance, and workflow optimizations for advanced cellular assays.

• Pharmacokinetics of CSBTA in MASH: Systemic and Hepatic Insi

  2026-05-17

  This study investigates how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids (CSBTA) in mice. The findings highlight the impact of pathological state and transporter/enzyme modulation on systemic and hepatic exposure, informing more precise dosing strategies in MASLD/MASH research.

• Troglitazone: PPARγ Agonist Workflows in Metabolism & Tumor

  2026-05-16

  Troglitazone is a benchmark PPARγ agonist uniquely suited for dissecting lipid and glucose metabolism as well as tumor microenvironment modulation. This article translates recent high-impact findings and product-specific guidance into actionable protocols, with a focus on advanced oncology use-cases and troubleshooting strategies.

• Nystatin (Fungicidin): Advancing Antifungal Assays with Mech

  2026-05-15

  Explore the advanced roles of Nystatin (Fungicidin) in antifungal research, with a focus on mechanistic depth, resistance challenges, and assay optimization. This article uniquely dissects practical assay decisions and experimental pitfalls, providing insights not covered in standard summaries.

• Ibuprofen as an Anti-Proliferative Agent: Protocols & Optimi

  2026-05-15

  Ibuprofen, or 2-[4-(2-methylpropyl)phenyl]propanoic acid, serves as a robust dual COX inhibitor for cancer and cardiovascular research workflows. This article delivers actionable, evidence-backed guidance for apoptosis induction, cell cycle arrest assays, and troubleshooting, leveraging APExBIO’s high-purity reagent for reproducible, translational results.

• GI 254023X: Precision ADAM10 Inhibition for Endothelial Defe

  2026-05-14

  Explore the advanced role of GI 254023X as a selective ADAM10 inhibitor in safeguarding vascular integrity and dissecting cellular signaling. This in-depth analysis highlights mechanistic nuances and practical assay insights not covered in prior content.

• Novel 14-3-3 Interactors ATG9A and PTOV1 in Cancer Regulatio

  2026-05-14

  This study identifies ATG9A and PTOV1 as new 14-3-3 binding partners, providing mechanistic insight into autophagy and oncogenic signaling in cancer. Using proteomics and targeted biochemical assays, the research details how phosphorylation-dependent interactions regulate protein stability and localization, illuminating new opportunities for targeted cancer interventions.

• Estradiol, GPR30, and ER Stress in CD4+ T Cell Recovery Afte

  2026-05-13

  This study demonstrates that 17β-estradiol restores splenic CD4+ T lymphocyte function after hemorrhagic shock by attenuating endoplasmic reticulum stress through both ERα and GPR30 signaling. The findings clarify how non-classical estrogen pathways contribute to immune normalization, providing targeted mechanistic insights for trauma-induced immunosuppression research.

15237 records 2/1016 page Previous Next 12345 下5页 Last page